Viewing StudyNCT00338650

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 4:52 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00338650
Status: COMPLETED
Last Update Posted: 2007-11-29
First Post: 2006-06-19
Brief Title: Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohns Disease With Previous Exposure to Infliximab CHOICE
Sponsor: Abbott
Organization: Abbott
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Crohns Disease
Keywords: